Fort Point Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.9M | Buy |
7,549
+643
| +9% | +$138K | 0.13% | 78 |
|
|
2026
Q1 | $1.5M | Buy |
6,906
+1,156
| +20% | +$256K | 0.18% | 79 |
|
|
2025
Q4 | $1.25M | Sell |
5,750
-19
| -0.3% | -$4.33K | 0.14% | 91 |
|
|
2025
Q3 | $1.34M | Sell |
5,769
-857
| -13% | -$175K | 0.16% | 90 |
|
|
2025
Q2 | $1.23M | Buy |
6,626
+231
| +4% | +$42.9K | 0.09% | 133 |
|
|
2025
Q1 | $1.34M | Sell |
6,395
-707
| -10% | -$137K | 0.15% | 102 |
|
|
2024
Q4 | $1.26M | Buy |
7,102
+1,211
| +21% | +$223K | 0.14% | 107 |
|
|
2024
Q3 | $1.16M | Buy |
5,891
+659
| +13% | +$123K | 0.14% | 98 |
|
|
2024
Q2 | $897K | Buy |
5,232
+42
| +0.8% | +$6.96K | 0.11% | 129 |
|
|
2024
Q1 | $945K | Sell |
5,190
-10
| -0.2% | -$1.72K | 0.13% | 126 |
|
|
2023
Q4 | $806K | Sell |
5,200
-1,138
| -18% | -$166K | 0.11% | 121 |
|
|
2023
Q3 | $945K | Sell |
6,338
-271
| -4% | -$39.8K | 0.14% | 93 |
|
|
2023
Q2 | $890K | Sell |
6,609
-650
| -9% | -$95.3K | 0.13% | 105 |
|
|
2023
Q1 | $1.16M | Buy |
7,259
+1,426
| +24% | +$218K | 0.18% | 94 |
|
|
2022
Q4 | $943K | Sell |
5,833
-666
| -10% | -$102K | 0.15% | 105 |
|
|
2022
Q3 | $872K | Sell |
6,499
-21
| -0.3% | -$3.01K | 0.15% | 108 |
|
|
2022
Q2 | $999K | Sell |
6,520
-137
| -2% | -$20.9K | 0.16% | 99 |
|
|
2022
Q1 | $1.08M | Buy |
6,657
+883
| +15% | +$128K | 0.15% | 101 |
|
|
2021
Q4 | $782K | Sell |
5,774
-5
| -0.1% | -$591 | 0.11% | 123 |
|
|
2021
Q3 | $623K | Buy |
5,779
+2,344
| +68% | +$268K | 0.09% | 118 |
|
|
2021
Q2 | $387K | Buy |
3,435
+100
| +3% | +$11.3K | 0.07% | 118 |
|
|
2021
Q1 | $361K | Buy |
3,335
+8
| +0.2% | +$856 | 0.08% | 116 |
|
|
2020
Q4 | $356K | Hold |
3,327
| – | – | 0.08% | 111 |
|
|
2020
Q3 | $291K | Sell |
3,327
-69,007
| -95% | -$6.5M | 0.07% | 111 |
|
|
2020
Q2 | $7.1M | Buy |
72,334
+177
| +0.2% | +$15.6K | 2.22% | 10 |
|
|
2020
Q1 | $5.5M | Sell |
72,157
-7,850
| -10% | -$669K | 2.36% | 10 |
|
|
2019
Q4 | $7.08M | Buy |
80,007
+1
| +0% | +$83 | 2.54% | 9 |
|
|
2019
Q3 | $6.06M | Buy |
80,006
+791
| +1% | +$54.2K | 2.28% | 10 |
|
|
2019
Q2 | $5.76M | Sell |
79,215
-36,786
| -32% | -$2.89M | 2.28% | 9 |
|
|
2019
Q1 | $9.35M | Sell |
116,001
-585
| -0.5% | -$47.9K | 4.08% | 6 |
|
|
2018
Q4 | $10.7M | Sell |
116,586
-165
| -0.1% | -$14.5K | 4.34% | 6 |
|
|
2018
Q3 | $11M | Buy |
116,751
+9
| +0% | +$853 | 3.33% | 7 |
|
|
2018
Q2 | $10.8M | Buy |
116,742
+458
| +0.4% | +$44.7K | 3.63% | 7 |
|
|
2018
Q1 | $11M | Sell |
116,284
-160
| -0.1% | -$17.6K | 4.03% | 6 |
|
|
2017
Q4 | $11.3M | Buy |
116,444
+1,023
| +0.9% | +$96.4K | 5.25% | 4 |
|
|
2017
Q3 | $10.3M | Buy |
115,421
+1,903
| +2% | +$145K | 4.91% | 4 |
|
|
2017
Q2 | $8.23M | Hold |
113,518
| – | – | 4.58% | 5 |
|
|
2017
Q1 | $7.4M | Sell |
113,518
-500
| -0.4% | -$31.4K | 3.81% | 6 |
|
|
2016
Q4 | $6.95M | Sell |
114,018
-2,279
| -2% | -$139K | 3.8% | 6 |
|
|
2016
Q3 | $7.33M | Buy |
116,297
+425
| +0.4% | +$27.5K | 3.32% | 8 |
|
|
2016
Q2 | $7.17M | Buy |
115,872
+600
| +0.5% | +$36.6K | 3.48% | 7 |
|
|
2016
Q1 | $6.58M | Buy |
115,272
+80
| +0.1% | +$4.46K | 3.35% | 7 |
|
|
2015
Q4 | $6.82M | Sell |
115,192
-1,338
| -1% | -$77.1K | 3.47% | 6 |
|
|
2015
Q3 | $6.34M | Buy |
116,530
+1,050
| +0.9% | +$68.3K | 3.89% | 6 |
|
|
2015
Q2 | $7.76M | Buy |
+115,480
| New | +$7.54M | 4.86% | 4 |
|
Other funds holding ABBV
Fort Point Capital Partners's ABBV Position: Q2 2026 in Review
Fort Point Capital Partners increased its AbbVie (ABBV) stake by 9.3% in Q2 2026, buying an estimated $138K and bringing the position to 7,549 shares worth $1.9M. The position accounts for 0.13% of the portfolio, ranked #78.
Fort Point Capital Partners first reported a position in ABBV in Q2 2015 and has held it in 45 quarters since. The position peaked at $11.3M in Q4 2017. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Fort Point Capital Partners held 7,549 shares of AbbVie worth $1.9M as of Q2 2026.
- Fort Point Capital Partners bought 643 AbbVie shares in Q2 2026, an estimated $138K.
- AbbVie made up 0.13% of Fort Point Capital Partners's portfolio in Q2 2026, its #78 holding.
- Fort Point Capital Partners first reported a position in AbbVie in Q2 2015 and has held it in 45 quarters since.
- Fort Point Capital Partners's AbbVie position peaked at $11.3M in Q4 2017.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Fort Point Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.